Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company achieved a steady revenue growth in the first half of 2025, with total revenue of 90.7 billion yuan, a slight decrease of 0.3% year-on-year, while net profit attributable to shareholders increased by 9% to 3.1 billion yuan, in line with expectations [1] - The overseas business showed significant growth, with foreign revenue increasing by 29% to 26.6 billion yuan, while domestic revenue fell by 9% [1] - The company plans to distribute a cash dividend of 610 million yuan, representing 19.69% of net profit attributable to shareholders [1] Financial Performance - The company's gross margin for the first half of 2025 was 9.6%, an increase of 0.2 percentage points year-on-year, with improvements in the construction segment [2] - Operating cash flow showed a net outflow of 10 billion yuan, but there was a significant improvement in cash flow in Q2, with a net inflow of 5.1 billion yuan, an increase of 29% year-on-year [2] - The company has a low interest-bearing debt ratio of 6.4%, with cash and cash equivalents amounting to 37.2 billion yuan, indicating a strong liquidity position [2] Order Intake and Future Outlook - New contracts signed from January to July 2025 totaled 224.8 billion yuan, a year-on-year increase of 4.4%, with a notable acceleration in growth since May [3] - The company is expected to benefit from the ongoing overseas market demand and domestic projects in Xinjiang's coal chemical sector, which may enhance order support [3] - Forecasted net profits for 2025-2027 are 6.41 billion, 7.27 billion, and 8.09 billion yuan, respectively, with corresponding EPS of 1.05, 1.19, and 1.32 yuan [3][5]
中国化学(601117):上半年业绩稳健增长,海外业务表现亮眼